Religare Enterprises Share Price in Focus; Subsidiary Gets Show Cause Notice From IRDAI

Care Health Insurance Limited (CHIL), a material subsidiary of Religare Enterprises Limited, has received a show cause notice from the Insurance Regulatory and Development Authority of India (IRDAI).  

The notice dated March 2, 2026, follows regulatory observations arising from a thematic onsite inspection conducted earlier by the insurance regulator. 

Inspection Observations Trigger Regulatory Action 

The regulatory communication stems from an inspection carried out between February 10, 2025, and February 14, 2025. The inspection focused on certain operational and regulatory compliance aspects of the insurer. 

According to the disclosure, the notice relates to alleged violations of multiple regulatory frameworks governing insurance operations in India. 

These include provisions under the Master Circular on Operations and Allied Matters of Insurer (2024), the Master Circular on Protection of Policyholders’ Interest (2024), and the Master Circular on Health Insurance Business (2024). 

Company Begins Remedial Steps 

The disclosure states that Care Health Insurance has already initiated remedial and appropriate measures in response to the regulator’s observations.

The insurer is currently preparing its formal reply to the show cause notice as advised by the regulatory authority. 

Religare Enterprises also clarified that there is currently no material impact on the company’s financials or operations due to the development. However, any penalty imposed after the regulatory process would be payable by Care Health Insurance. 

Read More: International Conveyors Acquires 3,60,000 Shares in Religare Enterprises for ₹7.50 Crore! 

Religare Enterprises Share Performance  

As of March 04, 2026, at 10:55 AM, Religare Enterprises share price is trading at ₹206.19 per share, reflecting a decline of 2.06% from the previous closing price.  

Conclusion 

The development highlights continued regulatory scrutiny within the insurance sector as authorities closely monitor compliance with evolving regulatory frameworks. Care Health Insurance is expected to submit its response to the regulator while addressing the observations raised during the inspection. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.